Comparison of all-cause costs and healthcare resource use among patients with newly-diagnosed non-valvular atrial fibrillation newly treated with oral anticoagulants.

Gilligan, Adrienne M; Franchino-Elder, Jessica; Song, Xue; Wang, Cheng; Henriques, Caroline; Sainski-Nguyen, Amy; Wilson, Kathleen; Smith, David M; Sander, Stephen

doi:10.1080/03007995.2017.1409425

Record: found
Abstract: found
Article: not found

Comparison of all-cause costs and healthcare resource use among patients with newly-diagnosed non-valvular atrial fibrillation newly treated with oral anticoagulants.

Author(s): Adrienne M Gilligan ¹ , Jessica Franchino-Elder ² , Xue Song ¹ , Cheng Wang ² , Caroline Henriques ¹ , Amy Sainski-Nguyen ¹ , Kathleen Wilson ¹ , David M Smith ¹ , Stephen Sander ²

Publication date (Electronic): Feb 2018

Journal: Current medical research and opinion

Publisher: Informa UK Limited

Keywords: Non-valvular atrial fibrillation, comparative effectiveness, cost, oral anticoagulants, outcomes, utilization

Read this article at

ScienceOpenPublisher PubMed

Bookmark

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Compare costs and healthcare resource utilization (HCRU) among newly-diagnosed non-valvular atrial fibrillation (NVAF) patients newly treated with dabigatran vs apixaban, rivaroxaban, or warfarin.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Curr Med Res Opin

Title: Current medical research and opinion

Publisher: Informa UK Limited

ISSN (Electronic): 1473-4877

ISSN (Print): 0300-7995

Publication date (Electronic): Feb 2018

Volume: 34

Issue: 2

Affiliations

[1 ] a Truven Health Analytics , an IBM Company , Cambridge , MA , USA.

[2 ] b Boehringer-Ingelheim Pharmaceuticals, Inc. , Ridgefield , CT , USA.

Article

DOI: 10.1080/03007995.2017.1409425

PubMed ID: 29166800

SO-VID: ed23e8a5-32ba-4ea3-9ade-50907b692ee0

History

Keywords: Non-valvular atrial fibrillation,utilization,outcomes,comparative effectiveness,oral anticoagulants,cost

Data availability:

Keywords: Non-valvular atrial fibrillation, utilization, outcomes, comparative effectiveness, oral anticoagulants, cost

Comparison of all-cause costs and healthcare resource use among patients with newly-diagnosed non-valvular atrial fibrillation newly treated with oral anticoagulants.

Read this article at

Abstract

Related collections

Resource Identification

Author and article information

Journal

Affiliations

Article

History

Comments

Comment on this article

Similar content 8

Cited by 4